Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

289 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations.
Moral-Sanz J, Fernandez-Rojo MA, Potriquet J, Mukhopadhyay P, Brust A, Wilhelm P, Smallwood TB, Clark RJ, Fry BG, Alewood PF, Waddell N, Miles JJ, Mulvenna JP, Ikonomopoulou MP. Moral-Sanz J, et al. Among authors: clark rj. Toxins (Basel). 2021 Feb 14;13(2):146. doi: 10.3390/toxins13020146. Toxins (Basel). 2021. PMID: 33672955 Free PMC article.
The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX, Kumar V, Clark RJ, Lee JD, Woodruff TM. Li XX, et al. Among authors: clark rj. Front Pharmacol. 2021 Jan 21;11:591398. doi: 10.3389/fphar.2020.591398. eCollection 2020. Front Pharmacol. 2021. PMID: 33551801 Free PMC article.
Defining the Familial Fold of the Vicilin-Buried Peptide Family.
Payne CD, Vadlamani G, Fisher MF, Zhang J, Clark RJ, Mylne JS, Rosengren KJ. Payne CD, et al. Among authors: clark rj. J Nat Prod. 2020 Oct 23;83(10):3030-3040. doi: 10.1021/acs.jnatprod.0c00594. Epub 2020 Sep 30. J Nat Prod. 2020. PMID: 32997497
289 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page